Ansell has been recognized for the contribution it has made through the Power of P.I.N.K. Program to Susan G. Komen for the Cure®. A letter personally signed by Susan G. Komen founder and CEO Nancy G. Brinker, credits Ansell's pioneering pink glove program for enabling Komen "to expand our mission to discover and deliver cures for breast cancer across the globe."
"I applaud everyone at Ansell Healthcare Products for your dedication and outstanding efforts," Brinker writes. "On behalf of my colleagues at Komen and the 2.5 million breast cancer survivors..., thank you for your continued support and tireless passion in the promise I made my sister. I have no doubt that lives were saved because of you."
"It's a very rare privilege to receive such an accolade from someone like Nancy Brinker, so we were quick to share the good news with the entire organization," says Patty Taylor, vice president of marketing at Ansell. "Making a difference is at the very core of who Ansell is, so this recognition is something we can all take pride in and everyone is thrilled."
Through its widely recognized pink glove program, Ansell contributes $2 from every case sold of its Micro-Touch® NitraFree pink nitrile exam gloves to Komen. Ansell's program began in 2008 and since then the softly tinted exam gloves have delivered a powerful blow in the fight against breast cancer.
"It's very fitting that every time a healthcare practitioner uses our signature pink exam gloves, they are not only protecting themselves, they are also helping Komen protect women everywhere from breast cancer and calling attention to a very important cause that is close to all of us," says Heather Campbell, senior marketing manager who initiated the program with Komen.
With Ansell's help, Komen invested an additional $75 million in research, increasing the number of their active projects to 582. Another $93 million was distributed to local communities, providing more than 600,000 women with free screenings and over 100,000 with treatment assistance.
Ansell is also encouraging women to get lifesaving breast screenings and mammograms as part of Komen's "Less Talk. More Action." campaign during Breast Cancer Awareness Month in October.
To view the full letter from Nancy G. Brinker or to obtain information on Ansell, its Power of P.I.N.K. (Partners in Nurturing and Knowledge) Program and its products, visit www.ansell.com/powerofpink/.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.